POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element

Molecular and Cellular Biology

Volumn 18, Issue 2, 1998, Pages 1029-1041

  Budhram Mahadeo, Vishwanie ^a   Parker, Malcolm ^b   Latchman, David S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; COMPLEX FORMATION; DNA BINDING; DNA SEQUENCE; GENE EXPRESSION REGULATION; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0031906243     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.2.1029     Document Type: Article

References (82)

1. Andersen, B., R. V. Pearse, P. N. Schleger, Z. Cichon, M. D. Marcus, C. W. Bardin, and M. G. Rosenfeld. 1993. Sperm-1: a POU domain gene transiently expressed immediately before meiosis 1 in the male germ cell. Proc. Natl. Acad. Sci. USA 90:11084-11088.
2. Andersen, B., M. D. Schoneman, R. V. Pearse, K. Jenne, J. Sugarman, and M. G. Rosenfeld. 1993. Brn-5 is a divergent POU domain factor highly expressed in layer IV of the neocortex. J. Biol. Chem. 268:23390-23398.
3. Aurora, R., and W. Herr. 1992. Segments of POU domain influence one another's DNA-binding specificity. Mol. Cell. Biol. 12:455-467.
4. Baniahmad, C., Z. Nawaz, A. Baniahmad, M. A. G. Gleeson, M. Tsi, and B. W. O'Malley. 1995. Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol. Endocrinol. 9:34-43.
5. Berthois, Y., J. A. Katzenellenbogen, and B. S. Katzenellenbogen. 1986. Phenol red tissue culture media is a weak estrogen: implications concerning the study of estrogen responsive cells in culture. Proc. Natl. Acad. Sci. USA 83:2496-2500.
6. Budhram-Mahadeo, V., T. Theil, P. J. Morris, K. A. Lillycrop, T. Moroy, and D. S. Latchman. 1994. The DNA target site for the Brn-3 POU family transcription factors can confer responsiveness to cyclic AMP and removal of serum in neuronal cells. Nucleic Acids Res. 22:3092-3098.
7. Budhram-Mahadeo, V., P. J. Morris, N. D. Lakin, T. Theil, G. Y. Ching, K. A. Lillycrop, T. Moroy, R. K. H. Liem, and D. S. Latchman. 1995. Activation of the α-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J. Biol. Chem. 270:2853-2858.
8. Budhram-Mahadeo, V., P. J. Morris, N. D. Lakin, S. J. Dawson, and D. S. Latchman. 1996. The different activities of the two activation domains of the Brn-3a transcription factor are dependent on the context of the binding site. J. Biol. Chem. 271:9108-9113.
9. Budhram-Mahadeo, V. 1995. Regulation and function of POU domain transcription factors, Brn-3a and Brn-3h. Ph.D. thesis. University of London, London, United Kingdom.
10. Catelli, M. G., N. Binart, I. Jung-Testas, J. M. Renoir, E. E. Baulieu, J. R. Feramisco, and W. J. Welch. 1985. The common 90-kd protein component of non-transformed 8s steroid receptors is a heat shock protein. EMBO J. 4:3131-3135.
11. Cavailles, V., S. Dauvios, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
12. Chang, W., W. Zhou, L. E. Theill, J. D. Baxter, and F. Schaufele. 1996. An activation function in Pit-1 required selectively for synergistic transcription. J. Biol. Chem. 271:17733-17738.
13. Ciocca, D. R., and L. M. Vargas Roig. 1995. Estrogen receptor in human nontarget tissues: biological and clinical implications. Endocr. Rev. 16:35-62.
14. Cunha, G. R., P. S. Cooke, R. Bigsby, and J. R. Brody. 1991. Ontogeny of sex steroid receptors in mammals, p. 235-268. In M. G. Parker (ed.), Nuclear hormone receptors. Academic Press, London, United Kingdom.
15. Dawson, S. J., P. J. Morris, and D. S. Latchman. 1996. A single amino acid change converts an inhibitory transcription factor into an activator. J. Biol. Chem. 271:11631-11633.
16. Day, R. N., S. Koike, M. Sakai, M. Muramatsu, and R. A. Maurer. 1990. Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol. Endocrinol. 12:1964-1971.
17. Fuqua, S. A., S. D. Fitzgerald, G. C. Chamness, A. K. Tandon, D. P. McDonnell, Z. Nawaz, B. W. O'Malley, G. L. Greene, and W. L. McGuire. 1991. Variant human breast tumour receptor with constitutive transcriptional activity. Cancer Res. 51:105-109.
18. Fuqua, S. A., S. D. Fitzgerald, D. C. Allred, R. M. Elledge, D. P. McDonnell, Z. Nawaz, B. W. O'Malley, G. L. Greene, and W. L. McGuire. 1992. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumours. Cancer Res. 52:483-486.
19. Garcia, T., S. Lehrer, W. D. Bloomer, and B. Schachter. 1988. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumours. Mol. Endocrinol. 3:687-693.
20. Gaub. M.-P., M. Bellard, I. Scheuer, P. Chambon, and P. Sassone-Corsi. 1990. Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell 63:1267-1276.
21. Gerrero, M. R., R. J. McEvilly, E. Turner, C. R. Lin, S. O'Connell, K. J. Jenne, M. V. Hobbs, and M. G. Rosenfeld. 1993. Brn-3.0, a POU domain protein expressed in the sensory, immune and endocrine systems that functions on elements distinct from known octamer motifs. Proc. Natl. Acad. Sci. USA 90:10841-10845.
22. Gorman, C. M. 1985. High efficiency transfer into mammalian cells, p. 143-190. In D. M. Glover (ed.), DNA cloning: a practical approach. IRL Press. Oxford, United Kingdom.
23. Green, S., and P. Chambon. 1991. The oestrogen receptor: from perspective to mechanism, p. 15-38. In M. G. Parker (ed.), Nuclear hormone receptors. Academic Press, London, United Kingdom.
24. Halachimi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
25. He, X., M. N. Treacy, D. M. Simmons, H. A. Ingraham, L. S. Swanson, and M. G. Rosenfeld. 1989. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340:35-12.
26. Herr, W., R. A. Strum, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, P. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, and H. R. Horvitz. 1988. The POU domain: a large conserved region in the mammalian pit-1 Oct-1, Oct-2 and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513-1516.
27. Holloway, J. M., D. P. Szeto, K. M. Scully, C. K. Glass, and M. G. Rosenfeld. 1995. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine dependent synergy domain. Genes Dev. 9:1992-2006.
28. Ince, B. A., Y. Zhuang, C. K. Wrenn, D. J. Shapiro, and B. S. Katzenellenbogen. 1993. Powerful dominant negative mutants of the human estrogen receptor. J. Biol. Chem. 268:14026-14032.
29. Ince, B. A., D. J. Schodin, D. J. Shapiro, and B. S. Katzenellenbogen. 1993. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptor. Endocrinology 136:3194-3199.
30. Keffer, D. A., and C. Holdregger. 1985. The ontogeny of the estrogen receptor: the brain and pituitary. Dev. Brain Res. 19:1386-1395.
31. Kuiper, G. G. M. J., E. Enmark, M. Pelto-Huikko, S. Nilsson, and J. A. Gustafsson. 1996. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93:5925-5930.
32. Kuiper, G. G. M. J., E. Enmark, M. Pelto-Huikko, S. Nilsson, and J. A. Gustafsson. 1996. Comparison of the ligand binding specificity and transcript tissue distribution of the estrogen receptor α and β. Endocrinology 138:863-870.
33. Kumar, V., and P. Chambon. 1988. The estrogen receptor binds tightly to its responsive element as a ligand induced homodimer. Cell 55:145-156.
34. Lai, J. S., M. A. Cleary, and W. Herr. 1992. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeodomain. Genes Dev. 6:2058-2065.
35. Lai, J. S., and W. Herr. 1992. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl. Acad. Sci. USA 89:6958-6962.
36. Lakin, N. D., P. J. Morris, T. Theil, T. N. Saro, T. Moroy, M. C. Wilson, and D. S. Latchman. 1995. Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor. J. Biol. Chem. 270:15858-15863.
37. Landel, C. C., P. J. Kushner, and F. L. Greene. 1994. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol. Endocrinol. 14:1407-1419.
38. Lannigan, D. A., and A. C. Notides. 1989. Estrogen receptor selectively binds the coding strand of an estrogen responsive element. Proc. Natl. Acad. Sci. USA 86:863-867.
39. Lannigan, D. A., and A. C. Notides. 1990. A novel mechanism for eukaryotic gene expression. The involvement of DNA tertiary structure in estrogen receptor recognition of its target nucleotide sequence. Biochem. Pharmacol. 40:2579-2585.
40. Lannigan, D. A., J. J. Tomashek, J. D. Obourn, and A. C. Notides. 1993. Analysis of estrogen receptor interaction with tertiary-structured estrogen responsive elements. Biochem. Pharmacol. 45:1921-1928.
41. Lannigan, D. A., N. J. Koszewski, and A. C. Notides. 1993. Estrogen-responsive elements contain non-B DNA. Mol. Cell. Endocrinol. 94:47-54.
42. Latchman, D. S. 1995. Eukaryotic transcription factors. 2nd ed. Academic Press, London, United Kingdom.
43. Latchman, D. S. 1998. Gene regulation - a eukaryotic perspective, 3rd ed. Chapman, London, United Kingdom.
44. Leygue, E. R., P. H. Watson, and L. C. Murphy. 1996. Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst. 88:284-290.
45. Lillycrop, K. A., V. Budhram-Mahadeo, N. D. Lakin, G. Terrenghi, J. N. Wood, J. M. Polak, and D. S. Latchman. 1992. A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res. 20:5093-5096.
46. Liu, Y. Z., S. J. Dawson, and D. S. Latchman. 1996. Alternative splicing of the Brn-3a and Brn-3b transcription factor mRNA is regulated in neuronal cells. J. Mol. Neurosci. 7:77-85.
47. Marsigliante, S., A. Muscella, V. Ciardo, J. R. Puddlefoot, G. Leo, G. P. Vinson, and C. Storelli. 1995. Multiple isoforms of the oestrogen receptor in endometrial cancer. J. Mol. Endocrinol. 14:365-374.
48. McGuire, W. L., G. C. Chamness, and S. A. Fuqua. 1992. Abnormal estrogen receptor in clinical breast cancer. J. Steroid Biochem. Mol. Biol. 43:243-247.
49. Migliaccio, A., M. Pagano, and F. Auricchio. 1993. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 8:2183-2191.
50. Monuki, E. S., R. Khun, G. Weinmaster, B. D. Trapp, and G. Lemke. 1990. Expression and activity of POU transcription factor SCIP. Science 249:1300-1303.
51. Morris, P. J., T. Theil, C. J. A. Ring, K. A. Lillycrop, T. Moroy, and D. S. Latchman. 1994. The opposite and antagonistic effects of the closely related POU family transcription factors Brn-3a and Brn-3b on the activity of a target promoter are dependent on differences in the POU domain. Mol. Cell. Biol. 14:6907-6914.
52. Mukherjee, R., and P. Chambon. 1990. A single-stranded DNA-binding protein promotes the binding of the purified oestrogen receptor to its response element. Nucleic Acids Res. 18:5713-5716.
53. Murphy, L. C., and H. Dolzlaw. 1989. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol. Endocrinol. 3:687-693.
54. Murphy, L. C., M. Wang, A. Coutt, and H. Dolzlaw. 1996. Novel mutations in the estrogen receptor messenger RNA in human breast cancers. J. Clin. Endocrinol. Metab. 81:1420-1427.
55. Ninkina, N. N., G. E. M. Stevens, J. N. Wood, and W. D. Richardson. 1993. A novel Brn-3 like POU transcription factor expressed in subsets of rat sensory and spinal cord neurons. Nucleic Acids Res. 21:3175-3182.
56. Onate, S. A., S. Y. Tsai, M-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
57. Parker, M. G. (ed.). 1991. Nuclear hormone receptors. Academic Press, London, United Kingdom.
58. Parker, M. G. 1993. Steroid and related receptors. Curr. Opin. Cell Biol. 1:512-518.
59. Pasqualini, J. R., and C. Sumida. 1986. Ontogeny of steroid receptors in the reproductive system. Int. Rev. Cytol. 101:275-315.
60. Patrone, C., Z. Q. Ma, G. Pollio, P. Agrati, M. G. Parker, and A. Maggi. 1994. Cross coupling between insulin and estrogen receptor in human neuroblastoma cell line. Mol. Endocrinol. 10:499-507.
61. Pomerantz, J. L., T. M. Kristie, and P. A. Sharp. 1992. Recognition of the surface of a homeo domain protein. Genes Dev. 11:2047-2057.
62. Pugh, B. F. 1996. Mechanisms of transcription complex assembly. Curr. Opin. Cell Biol. 8:303-311.
63. Ritchie, M. E., R. V. Trask, H. L. Fontanet, and J. J. Billadello. 1991. Multiple positive and negative elements regulate human brain creatine kinase gene expression. Nucleic Acids Res. 19:6231-6240.
64. Scholer, H. R., S. Ruppert, N. Suzuki, K. Chowdhury, and P. Gruss. 1990. New type of POU domain in germline specific protein Oct-4. Nature 344: 435-439.
65. Scoville, S. A., S. M. Bufton, and F. J. Liuzzi. 1997. Estrogen regulates neurofilament gene expression in adult rat dorsal root ganglion neurons. Exp. Neurol. 146:586-599.
66. Shughrue, P. J., B. Komme, and I. Merchenthaler. 1996. The distribution of estrogen receptor beta mRNA in the rat hypothalamus. Steroids 61:678-681.
67. Sukovich, D. A., R. Mukherjee, and P. A. Benfield. 1994. A novel cell-type-specitic mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive clement. Mol. Cell. Biol. 14:7134-7143.
68. Suzuki, N., H. Rohdewold, T. Neuman, P. Gruss, and H. R. Schuler. 1990. Oct-6: a POU transcription factor expressed in embryonal stem cells and in developing brain. EMBO J. 9:3723-3732.
69. Theil, T., S. McLean-Hunter, M. Zornig, and T. Moroy. 1993. Mouse Brn-3 family of POU transcription factors: a new amino terminal domain is crucial for the oncogenic activity of Brn-3A. Nucleic Acids Res. 21:5921-5929.
70. Theil, T., U. Zechner, C. Klett, S. Adolph, and T. Moroy. 1994. Chromosomal localization and cDNA sequences of the murine Brn-3 family of developmental control genes. Cytogenet. Cell Genet. 66:267-271.
71. Theil, T., B. Rodel, F. Spiegelhalter, and T. Moroy. 1995. Short isoform of POU factor Brn-3b can form a heterodimer with Brn-3a that is inactive for octamer motif binding. J. Biol. Chem. 270:30958-30964.
72. Tjian, R., and T. Maniatis. 1994. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5-8.
73. Treacy, M. N., and M. G. Rosenfeld. 1992. Expression of a family of POU-domain protein regulatory genes during development of the central nervous system. Annu. Rev. Neurosci. 15:139-165.
74. Turner, E. E., K. J. Jenne, and M. G. Rosenfeld. 1994. Brn-3.2: a Brn-3-relaled transcription factor with distinctive central nervous system expression and regulation by retinoic acid. Neuron 12:205-218.
75. Umayahara, Y., R. Kawamori, H. Watada, E. Imano, N. Iwama, T. Morishima, Y. Yamasaki, Y. Kajimoto, and T. Kamada. 1994. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:16433-16442.
76. Verrijzer, C. P., J. A. W. M. van Oosterhout, and P. C. van der Vliet. 1992. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins. Mol. Cell. Biol. 12:542-551.
77. Verrijzer, C. P., and P. C. van der Vliet. 1993. POU domain transcription factors. Biochim. Biophys. Acta 1173:1-21.
78. Wang, H., G. A. Peters, X. Zeng, M. Tang, and S. A. Khan. 1995. Yeast two hybrid system demonstrates that estrogen receptor dimerization is ligand dependent in vivo. J. Biol. Chem. 270:23322-23329.
79. Webb, P., G. N. Lopez, R. M. Uht, and P. J. Kushner. 1995. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:443-456.
80. Wegner, M., D. W. Drolet, and M. G. Rosenfeld. 1993. POU-domain proteins: structure and function of developmental regulators. Curr. Opin. Cell Biol. 5:488-498.
81. Xia, Y., B. Andersen, M. Mehrabain, A. T. Diep, C. H. Warden, T. Mohandas, R. J. McEvilly, M. G. Rosenfeld, and A. J. Lusis. 1993. Chromosomal organization of mammalian POU domain factors. Genomics 18:126-130.
82. Yang, N. N., M. Venugopalan, S. Hardikar, and A. Glasebrook. 1996. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222-1225.